Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition

Table 1 Summary chemotherapy and immunotherapy agents received by patient 1

Treatments	Duration
Cisplatin, paclitaxel^a, gemcitabine	Six cycles
Nivolumab	28 cycles (56 weeks)^b
Ipilimumab	2 cycles (6 weeks)^c

^aPaclitaxel was stopped after first cycle due to grade 3 toxicity
^bAt the time of submission of this manuscript, 28 cycles were completed but nivolumab will be continued
^cAt the time of submission of this manuscript, 2 cycles were given and will be continued for 2 more cycles